Alyeska Investment Group’s Arcturus Therapeutics ARCT Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $1.33M | Buy |
+102,518
| New | +$1.33M | ﹤0.01% | 489 |
|
2017
Q1 | – | Sell |
-116,359
| Closed | -$1.71M | – | 448 |
|
2016
Q4 | $1.71M | Sell |
116,359
-34,938
| -23% | -$513K | 0.01% | 389 |
|
2016
Q3 | $2.62M | Buy |
151,297
+4,122
| +3% | +$71.3K | 0.02% | 360 |
|
2016
Q2 | $4.63M | Sell |
147,175
-2,698
| -2% | -$84.8K | 0.04% | 308 |
|
2016
Q1 | $3.98M | Buy |
149,873
+6,950
| +5% | +$184K | 0.04% | 288 |
|
2015
Q4 | $6.28M | Buy |
142,923
+63,584
| +80% | +$2.8M | 0.07% | 246 |
|
2015
Q3 | $3.35M | Buy |
+79,339
| New | +$3.35M | 0.04% | 289 |
|